IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG
Product details
Registration number: SIN14765P
Classification: Prescription Only
Active ingredients:
- Imipenem Monohydrate 530mg/vial eqv Imipenem
- Sodium Cilastatin 530mg/vial eqv Cilastatin
Strength:
- 500mg/ vial
- 500mg/ vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
ATC code: J01DH51
HSA approval date: 26 March 2015
Manufacturer(s):
- ACS Dobfar S.p.A (primary and secondary packager)
- ACS Dobfar SpA (sterile bulk blend)
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14765P
Classification: Prescription Only
What active ingredients and strength are recorded for IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Imipenem Monohydrate 530mg/vial eqv Imipenem
- Sodium Cilastatin 530mg/vial eqv Cilastatin
Strength:
- 500mg/ vial
- 500mg/ vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- ACS Dobfar S.p.A (primary and secondary packager)
- ACS Dobfar SpA (sterile bulk blend)
Manufacturing country/countries: ITALY
Where can I look up IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14765P or the exact product name IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG. The general register link does not preselect this product.
What are the source dates for this IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this IMIPENEM /CILASTATIN KABI POWDER FOR SOLUTION FOR INFUSION 500MG/500MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14765P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)